P75-20435-78825
1 vaccination
1 coded response
2 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 662 / KS
- Registered
- 2021-02-17
- Relationship
- Self
Timeline
-
2021-02-17
Registered in v-safe
-
2021-02-17
Dose 1 — Pfizer-BioNTech
-
2021-02-17
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Sore arm where shot was givenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-18
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 4 — day 0, dose 1
Systemic reaction (other): Sore arm where shot was given
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Immediate post-injection reaction | ○ | ○ | ○ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release